Validations: Deviation, OOS/OOT Trending & CAPA Effectiveness

Sustaining Gains: ECs Beyond the First Success

Sustaining Gains: ECs Beyond the First Success Sustaining Gains: ECs Beyond the First Success Introduction to Deviation Management in Pharmaceutical Quality In the highly regulated pharmaceutical industry, deviation management is an essential component of maintaining product quality and ensuring compliance with relevant regulatory bodies, including the US FDA, EMA, and MHRA. Understanding the nuances of OOS (Out of Specification) investigations,…

Continue Reading Sustaining Gains: ECs Beyond the First Success

EC Triggers for Re-Opening CAPA

EC Triggers for Re-Opening CAPA In the pharmaceutical industry, effective deviation management, OOS (Out of Specification) investigations, and OOT (Out of Trend) trending are critical for maintaining compliance and ensuring product quality. Understanding how to properly handle CAPA (Corrective and Preventive Action) processes is essential for pharmaceutical professionals. This comprehensive guide will walk you through the intricacies of re-opening CAPA…

Continue Reading EC Triggers for Re-Opening CAPA

EC Triggers for Re-Opening CAPA

EC Triggers for Re-Opening CAPA EC Triggers for Re-Opening CAPA: A Step-by-Step Guide In the highly regulated pharmaceutical environment, the effective management of deviations, Out of Specification (OOS) investigations, and Out of Trend (OOT) assessments is crucial for compliance and product integrity. The importance of robust Corrective and Preventive Action (CAPA) systems cannot be overstated, especially when it comes to…

Continue Reading EC Triggers for Re-Opening CAPA

Avoiding Goodhart’s Law in CAPA Metrics

Avoiding Goodhart’s Law in CAPA Metrics Avoiding Goodhart’s Law in CAPA Metrics In the realm of pharmaceutical quality management, the integrity of metrics is critical. This article outlines a step-by-step tutorial on how to avoid Goodhart’s Law when designing CAPA (Corrective and Preventive Action) metrics, focusing on deviation management, OOS (Out of Specification) investigations, and OOT (Out of Trend) trending….

Continue Reading Avoiding Goodhart’s Law in CAPA Metrics

Avoiding Goodhart’s Law in CAPA Metrics

Avoiding Goodhart’s Law in CAPA Metrics Avoiding Goodhart’s Law in CAPA Metrics Introduction to Goodhart’s Law and CAPA Metrics Goodhart’s Law states that “When a measure becomes a target, it ceases to be a good measure.” This principle can create challenges in the pharmaceutical quality management system, particularly within Corrective and Preventive Action (CAPA) processes. In efforts to enhance deviation…

Continue Reading Avoiding Goodhart’s Law in CAPA Metrics

ECs for Supplier/CMO CAPA

ECs for Supplier/CMO CAPA Effectiveness Checks for Supplier/CMO CAPA In the pharmaceutical industry, the management of deviations, Out of Specification (OOS) results, and Out of Trend (OOT) observations is crucial for maintaining compliance with regulatory standards and ensuring product quality. This comprehensive tutorial aims to provide a structured step-by-step guide on designing effectiveness checks (ECs) for Corrective and Preventive Actions…

Continue Reading ECs for Supplier/CMO CAPA

ECs for Supplier/CMO CAPA

ECs for Supplier/CMO CAPA Effectiveness Checks for Supplier/CMO CAPA Management In the pharmaceutical industry, maintaining compliance with regulatory standards while addressing deviations, Out-of-Specification (OOS) results, and Out-of-Trend (OOT) occurrences is critical. This comprehensive, step-by-step tutorial guides you through establishing effective checks in the corrective and preventive action (CAPA) system, ensuring a robust framework for managing deviations and enhancing process quality….

Continue Reading ECs for Supplier/CMO CAPA

Human Factors: Training Retention & Drift

Human Factors: Training Retention & Drift Human Factors: Training Retention & Drift In pharmaceutical manufacturing, the adherence to regulatory compliance and consistent quality assurance is paramount. As the industry evolves, the integration of human factors into training programs becomes increasingly critical. This tutorial guide delineates the processes related to training retention and drift while emphasizing the importance of deviation management,…

Continue Reading Human Factors: Training Retention & Drift

Human Factors: Training Retention & Drift

Human Factors: Training Retention & Drift Human Factors: Training Retention & Drift In the context of pharmaceutical validation, understanding human factors is essential for effective deviation management and ensuring compliance with regulatory expectations. Human factors significantly impact training retention and drift, which in turn, influence the quality of processes and products in pharmaceutical companies. This article aims to provide a…

Continue Reading Human Factors: Training Retention & Drift

Leading vs Lagging Indicators: Choosing the Right Mix

Leading vs Lagging Indicators: Choosing the Right Mix In the context of pharmaceutical quality systems, especially under the guidelines of ICH Q10, managing deviations effectively is crucial for ensuring that products meet regulatory requirements while also maintaining a high standard of quality. This tutorial provides an in-depth overview of leading versus lagging indicators within the framework of deviation management, Out…

Continue Reading Leading vs Lagging Indicators: Choosing the Right Mix